Ted W Johnson Selected Research

Ted W Johnson Research Topics

6	Neoplasms (Cancer) 01/2023 - 01/2013
6	Lung Neoplasms (Lung Cancer) 10/2022 - 07/2015
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 06/2014
1	Disease Progression 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2019
1	Liver Failure 01/2016
1	Brain Neoplasms (Brain Tumor) 07/2015
1	Glioblastoma (Glioblastoma Multiforme) 03/2015

7	lorlatinibIBA 10/2022 - 03/2015
5	CrizotinibIBA 01/2021 - 02/2014
4	Anaplastic Lymphoma KinaseIBA 01/2022 - 06/2014
2	hematopoietic progenitor kinase 1IBA 01/2023 - 01/2019
2	Tyrosine Kinase InhibitorsIBA 10/2022 - 01/2022
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021 - 01/2019
2	Phosphotransferases (Kinase)IBA 03/2015 - 01/2013
1	cabozantinibIBA 01/2021
1	entrectinibIBA 01/2021
1	Sunitinib (Sutent)FDA Link 01/2019
1	AminopyridinesIBA 02/2014
1	2- amino- 8- (4- (2- hydroxyethoxy)cyclohexyl)- 6- (6- methoxypyridin- 3- yl)- 4- methylpyrido(2,3- d)pyrimidin- 7(8H)- oneIBA 01/2013

6	Therapeutics 01/2023 - 03/2015